Table 2.
Prevention strategies for postoperative pulmonary complications.
| Options | Proposed mechanisms | |
|---|---|---|
| Mechanical factors | Miniaturized CPB circuit | Decrease contact activation, decreased hemodilution |
| Coated CPB circuit (heparin, PMEA) | Decrease contact activation | |
| Leukocyte filtration | Remove activated leukocytes, especially for longer CPB duration | |
| Retrograde autologous priming (RAP) | Decrease hemodilution | |
| Ultrafiltration (modified, zero-balance) | Hemoconcentration, filtration of mediators | |
| Normoxia on CPB | Reduce reperfusion injury with free oxygen radicals | |
| Surgical technique | Avoid CPB if possible | |
| Reduce the duration of time on CPB | Reduction in time available for inflammation/ischemic injury to lungs | |
| Cardioprotection with cardioplegia | Prevent ischemia–reperfusion injury | |
| Minimize cardiotomy suction | Decrease blood–air contact; decrease activation of inflammatory response | |
| Transfusion-sparing techniques | Decrease inflammation/immune responses to transfusion | |
| Partial lung perfusion | Decrease ischemia to lungs, more complicated surgical procedure | |
| Anesthesia factors | Intermittent ventilation | Prevent atelectasis |
| Recruitment maneuver | Reduce atelectasis, improve respiratory mechanics, reduce volutrauma | |
| Low tidal volume ventilation | Prevent shear stress, various types of trauma to lungs: volutrauma, barotraumas, and atelectatrauma | |
| Volatile anesthesia-based | ||
| Medications | Steroids | Modulate immune response, potential negative impact on glucose control and wound healing |
| Neutrophil elastase inhibitors | Inhibit neutrophil elastase and reduce leukocyte sequestration in the lungs | |
| Hypertonic saline | Decrease extravascular lung water, improve oxygenation | |
| Aprotonin | Decrease extravascular lung water, improve oxygenation, and reduce neutrophil sequestration |